Harmony Biosciences Holdings, Inc. today announced that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for pitolisant for the treatment of excessive ...

The S&P 500 closed at a new all-time high. Homebuilder sentiment fell to its lowest level in five months. Shares of Intel ...

U.S. single-family homebuilding fell sharply in January amid disruptions from snowstorms and freezing temperatures, with a ...

Stock futures moved mostly lower as investors await new info from the Fed and consider the latest White House tariff proposal, which would add a 25% import tax on automobiles, pharmaceuticals and ...

Allied Market AMR report on the electric vehicle battery market states that focus on mitigating emissions & rise in fuel prices have opened ...

U.S. Federal Reserve officials remain uncertain about the impact tariffs might have on inflation, but have begun outlining ...

NPR talks to David Wessel, director of the Hutchins Center at the Brookings Institution, about what's driving the recent market surge and whether high valuations signal strength or speculation.

In our analysis, these 12 brokerage accounts stand out as the best choices for stock trading, due to their low fees, strong platforms and quality customer support. Many, or all, of the products ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

Buying stocks is quick and straightforward once you have a brokerage account. Learn how with this step-by-step guide. Many, or all, of the products featured on this page are from our advertising ...

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology firm specializing in regenerative medicine with a market capitalization of approximately $7 million, has revealed promising one-year follow-up ...